Class II
Ongoing
Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC…
Why: CGMP Deviations
- Company
- Baxter Healthcare Corporation
Deerfield, IL, United States - Reported
- Sep 9, 2026
- Recall started
- Aug 6, 2026
- Where sold
- US Nationwide; Puerto Rico; and Chile.
- Amount
- N/A
- Full product description
- Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.
- Lots / codes affected
- Lot # NC193894, Exp Date: 04/25/2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.